Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan N Basile

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 1, 2017
Hypertension and Its Complications in a Young Man With Autoimmune DiseaseEve Miller-Hodges, Anna F Dominiczak, Garry L R Jennings, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2016
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyMichael A Weber, Michael Bloch, George L Bakris, et al.
The American Journal of Cardiology|July 12, 2007
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialWilliam C Cushman, Richard H Grimm, Jeffrey A Cutler, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2004
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT studyJoshua I Barzilay, Barry R Davis, Judy Bettencourt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
American Journal of Hypertension|April 18, 2009
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trialBrent M Egan, Jan N Basile, Shakaib U Rehman, et al.
Journal of General Internal Medicine|July 9, 2014
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHATLinda B Piller, Lara M Simpson, Sarah Baraniuk, et al.
Hypertension (Dallas, Tex. : 1979)|August 10, 2016
Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic SignificanceJerome L Fleg, Gregory W Evans, Karen L Margolis, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Richard H. Grimm, Karen L. Margolis, Vasilios Papademetriou, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Hypertension (Dallas, Tex. : 1979)|March 1, 2017
Hypertension and Its Complications in a Young Man With Autoimmune DiseaseEve Miller-Hodges, Anna F Dominiczak, Garry L R Jennings, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2016
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH SubstudyMichael A Weber, Michael Bloch, George L Bakris, et al.
The American Journal of Cardiology|July 12, 2007
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialWilliam C Cushman, Richard H Grimm, Jeffrey A Cutler, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2004
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT studyJoshua I Barzilay, Barry R Davis, Judy Bettencourt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
American Journal of Hypertension|April 18, 2009
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trialBrent M Egan, Jan N Basile, Shakaib U Rehman, et al.
Journal of General Internal Medicine|July 9, 2014
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHATLinda B Piller, Lara M Simpson, Sarah Baraniuk, et al.
Hypertension (Dallas, Tex. : 1979)|August 10, 2016
Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic SignificanceJerome L Fleg, Gregory W Evans, Karen L Margolis, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Richard H. Grimm, Karen L. Margolis, Vasilios Papademetriou, et al.
Pageof 11